Detalhe da pesquisa
1.
Cardiac Safety of Dual Anti-HER2 Therapy in the Neoadjuvant Setting for Treatment of HER2-Positive Breast Cancer.
Oncologist
; 22(6): 642-647, 2017 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-28341761
2.
Pathologic Complete Response with Neoadjuvant Doxorubicin and Cyclophosphamide Followed by Paclitaxel with Trastuzumab and Pertuzumab in Patients with HER2-Positive Early Stage Breast Cancer: A Single Center Experience.
Oncologist
; 22(2): 139-143, 2017 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-28167568
4.
Efficacy and Safety of Gemcitabine With Trastuzumab and Pertuzumab After Prior Pertuzumab-Based Therapy Among Patients With Human Epidermal Growth Factor Receptor 2-Positive Metastatic Breast Cancer: A Phase 2 Clinical Trial.
JAMA Netw Open
; 2(11): e1916211, 2019 11 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31774522
5.
Effect of age on drug metabolism in women with breast cancer.
Expert Opin Drug Metab Toxicol
; 11(5): 757-66, 2015 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-25940027